Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Sale of 1,864 VCYT shares, $80.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | VERACYTE, INC. (VCYT) | Sale | 1,864 | $80.1K |
| Jun 18, 2026 | ARDELYX, INC. (ARDX) | Grant/Award | 26,455 | n/a |
| Jun 15, 2026 | VERACYTE, INC. (VCYT) | Grant/Award | 5,272 | n/a |
| Jun 10, 2026 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 9,200 | n/a |
| May 27, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 2,851 | n/a |
| Jun 24, 2025 | ARDELYX, INC. (ARDX) | Grant/Award | 41,551 | n/a |
| Jun 23, 2025 | VERACYTE, INC. (VCYT) | Grant/Award | 9,321 | n/a |
| Jun 17, 2025 | VERACYTE, INC. (VCYT) | Sale | 4,589 | $122.4K |
| Jun 13, 2025 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 8,000 | n/a |
| May 15, 2025 | CYTOKINETICS INC (CYTK) | Sale | 1,454 | $43.2K |